
Please try another search
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical or pending clinical studies for brain and other cancers. The company is headquartered in Jerusalem, Israel.
Name | Age | Since | Title |
---|---|---|---|
Yona Keisari | 78 | 2019 | Chief Scientific Officer & Member of Scientific Advisory board |
David M. Milch | 71 | 2022 | Independent Director |
Alan Adler | 84 | 2018 | Independent Director |
Uzi Sofer | 55 | 2015 | CEO & Chairman |
Michael J. Zelefsky | 65 | - | Member of Scientific Advisory Board |
Robert B. Den | 46 | 2019 | Chief Medical Officer & Member of Scientific Advisory Board |
Aron Popovtzer | - | - | Member of Scientific Advisory Board |
S. Morry Blumenfeld | 87 | 2016 | Independent Director |
Ruth Alon | 73 | 2022 | Independent Director |
Michael Avruch | 55 | 2016 | Director |
Itzhak Kelson | 85 | 2016 | Chief Physics Officer & Member of Scientific Advisory Board |
Stephen M. Hahn | - | 2023 | Member of Scientific Advisory Board |
Maya Racine-Netser | 55 | 2024 | Independent Director |
Nadav Kidron | 51 | 2025 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review